BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6715398)

  • 21. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
    Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
    Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
    Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
    Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
    Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types.
    Kao GF; Norris HJ
    Obstet Gynecol; 1979 Dec; 54(6):729-36. PubMed ID: 514560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor.
    Akbarzadeh-Jahromi M; Shekarkhar G; Sari Aslani F; Azarpira N; Heidari Esfahani M; Momtahan M
    Arch Iran Med; 2015 Dec; 18(12):844-8. PubMed ID: 26621017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precursor lesions of ovarian epithelial malignancy.
    Feeley KM; Wells M
    Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ras oncogene product p21 expression and prognosis of human ovarian tumors.
    Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
    Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXA1 is expressed in ovarian mucinous neoplasms.
    Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
    Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of neuroendocrine cells in ovarian mucinous tumors.
    Sasaki E; Sasano N; Kimura N; Andoh N; Yajima A
    Int J Gynecol Pathol; 1989; 8(3):189-200. PubMed ID: 2570045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
    Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
    Chui MH; Ellenson LH
    Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
    Rutgers JL; Scully RE
    Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.